Possible Association Between Obesity and Clostridium Difficile Infection

Overview

Journal Emerg Infect Dis

Specialty Infectious Diseases

Date 2013 Nov 6

PMID 24188730

Citations 33

Authors

Jason Leung

Bob Burke

Dale Ford

Gail Garvin

Cathy Korn

Carol Sulis

Nahid Bhadelia

Affiliations

Soon will be listed here.

Citing Articles

Association of the oxidative balance score with obesity and body composition among young and middle-aged adults.

Zhu Z, Bai H, Li Z, Fan M, Li G, Chen L Front Nutr. 2024; 11:1373709.

PMID: 38751744 PMC: 11095126. DOI: 10.3389/fnut.2024.1373709.

From-Toilet-to-Freezer: A Review on Requirements for an Automatic Protocol to Collect and Store Human Fecal Samples for Research Purposes.

Widjaja F, Rietjens I Biomedicines. 2023; 11(10).

PMID: 37893032 PMC: 10603957. DOI: 10.3390/biomedicines11102658.

Comparison of the Effect of Corn-fermented Protein and Traditional Ingredients on the Fecal Microbiota of Dogs.

Kilburn-Kappeler L, Doerksen T, Lu A, Palinski R, Lu N, Aldrich C Vet Sci. 2023; 10(9).

PMID: 37756074 PMC: 10536651. DOI: 10.3390/vetsci10090553.

Epidemiological and microbiome associations of carriage in infancy and early childhood.

Mani J, Levy S, Angelova A, Hazrati S, Fassnacht R, Subramanian P Gut Microbes. 2023; 15(1):2203969.

PMID: 37096914 PMC: 10132246. DOI: 10.1080/19490976.2023.2203969.

Is Increased BMI a Risk Factor for Developing Severe Clostridioides Difficile Infection? A Retrospective Study.

Chatterjee T, Bansal S, Abuzar A, Hussain H, Gupta L J Community Hosp Intern Med Perspect. 2023; 12(6):43-50.

PMID: 36816160 PMC: 9924641. DOI: 10.55729/2000-9666.1123.

References

Greenblum S, Turnbaugh P, Borenstein E . Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. Proc Natl Acad Sci U S A. 2011; 109(2):594-9. PMC: 3258644. DOI: 10.1073/pnas.1116053109. View

Bignardi G . Risk factors for Clostridium difficile infection. J Hosp Infect. 1998; 40(1):1-15. DOI: 10.1016/s0195-6701(98)90019-6. View

Musa S, Thomson S, Cowan M, Rahman T . Clostridium difficile infection and inflammatory bowel disease. Scand J Gastroenterol. 2009; 45(3):261-72. DOI: 10.3109/00365520903497098. View

Navaneethan U, Venkatesh P, Shen B . Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship. World J Gastroenterol. 2010; 16(39):4892-904. PMC: 2957597. DOI: 10.3748/wjg.v16.i39.4892. View

. Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep. 2012; 61(9):157-62. View

Bishara J, Farah R, Mograbi J, Khalaila W, Abu-Elheja O, Mahamid M . Obesity as a risk factor for Clostridium difficile infection. Clin Infect Dis. 2013; 57(4):489-93. DOI: 10.1093/cid/cit280. View

Li E, Hamm C, Gulati A, Sartor R, Chen H, Wu X . Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition. PLoS One. 2012; 7(6):e26284. PMC: 3374607. DOI: 10.1371/journal.pone.0026284. View

DiBaise J, Zhang H, Crowell M, Krajmalnik-Brown R, Decker G, Rittmann B . Gut microbiota and its possible relationship with obesity. Mayo Clin Proc. 2008; 83(4):460-9. DOI: 10.4065/83.4.460. View

Rodemann J, Dubberke E, Reske K, Seo D, Stone C . Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007; 5(3):339-44. DOI: 10.1016/j.cgh.2006.12.027. View

10.

Clemente J, Ursell L, Parfrey L, Knight R . The impact of the gut microbiota on human health: an integrative view. Cell. 2012; 148(6):1258-70. PMC: 5050011. DOI: 10.1016/j.cell.2012.01.035. View

11.

Mitchell B, Gardner A . Prolongation of length of stay and Clostridium difficile infection: a review of the methods used to examine length of stay due to healthcare associated infections. Antimicrob Resist Infect Control. 2012; 1(1):14. PMC: 3436661. DOI: 10.1186/2047-2994-1-14. View

12.

. Severe Clostridium difficile-associated disease in populations previously at low risk--four states, 2005. MMWR Morb Mortal Wkly Rep. 2005; 54(47):1201-5. View

13.

Kwok C, Arthur A, Anibueze C, Singh S, Cavallazzi R, Loke Y . Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol. 2012; 107(7):1011-9. DOI: 10.1038/ajg.2012.108. View

14.

McGlone S, Bailey R, Zimmer S, Popovich M, Tian Y, Ufberg P . The economic burden of Clostridium difficile. Clin Microbiol Infect. 2011; 18(3):282-9. PMC: 3763211. DOI: 10.1111/j.1469-0691.2011.03571.x. View

15.

Issa M, Vijayapal A, Graham M, Beaulieu D, Otterson M, Lundeen S . Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007; 5(3):345-51. DOI: 10.1016/j.cgh.2006.12.028. View

16.

Gase K, Haley V, Xiong K, Van Antwerpen C, Stricof R . Comparison of 2 Clostridium difficile surveillance methods: National Healthcare Safety Network's laboratory-identified event reporting module versus clinical infection surveillance. Infect Control Hosp Epidemiol. 2013; 34(3):284-90. DOI: 10.1086/669509. View

17.

. Surveillance for community-associated Clostridium difficile--Connecticut, 2006. MMWR Morb Mortal Wkly Rep. 2008; 57(13):340-3. View

18.

Mathur R, Amichai M, Chua K, Mirocha J, Barlow G, Pimentel M . Methane and hydrogen positivity on breath test is associated with greater body mass index and body fat. J Clin Endocrinol Metab. 2013; 98(4):E698-702. PMC: 3615195. DOI: 10.1210/jc.2012-3144. View

19.

Young V, Schmidt T . Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J Clin Microbiol. 2004; 42(3):1203-6. PMC: 356823. DOI: 10.1128/JCM.42.3.1203-1206.2004. View

20.

Cohen S, Gerding D, Johnson S, Kelly C, Loo V, McDonald L . Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010; 31(5):431-55. DOI: 10.1086/651706. View